Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.
<h4>Background/objective</h4>Weight loss is a predictor of shorter survival in amyotrophic lateral sclerosis (ALS). We performed serial measures of body composition using Dual-energy X-ray Absorptiometry (DEXA) in ALS patients to explore its utility as a biomarker of disease progression....
Guardado en:
Autores principales: | Ikjae Lee, Mohamed Kazamel, Tarrant McPherson, Jeremy McAdam, Marcas Bamman, Amy Amara, Daniel L Smith, Peter H King |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cbf11b03b4c740548528a386c9a157d3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis
por: Thaddaeus Kwan, et al.
Publicado: (2020) -
Amyotrophic lateral sclerosis and frontotemporal degeneration
Publicado: (2000) -
The cortical signature of amyotrophic lateral sclerosis.
por: Federica Agosta, et al.
Publicado: (2012) -
Abnormal RNA stability in amyotrophic lateral sclerosis
por: E. M. Tank, et al.
Publicado: (2018) -
Current and emerging treatments for amyotrophic lateral sclerosis
por: Stefano Zoccolella, et al.
Publicado: (2009)